195 related articles for article (PubMed ID: 33384677)
21. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
J Virol; 2024 Jun; ():e0067924. PubMed ID: 38842335
[TBL] [Abstract][Full Text] [Related]
22. Indole alkaloids inhibit zika and chikungunya virus infection in different cell lines.
Monsalve-Escudero LM; Loaiza-Cano V; Pájaro-González Y; Oliveros-Díaz AF; Diaz-Castillo F; Quiñones W; Robledo S; Martinez-Gutierrez M
BMC Complement Med Ther; 2021 Aug; 21(1):216. PubMed ID: 34454481
[TBL] [Abstract][Full Text] [Related]
23. Antiviral activity of nobiletin against chikungunya virus in vitro.
Lin SC; Chen MC; Li S; Lin CC; Wang TT
Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
[TBL] [Abstract][Full Text] [Related]
24. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
[TBL] [Abstract][Full Text] [Related]
25. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
[TBL] [Abstract][Full Text] [Related]
26. Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus.
Rabelo VW; da Silva VD; Sanchez Nuñez ML; Dos Santos Corrêa Amorim L; Buarque CD; Kuhn RJ; Abreu PA; Nunes de Palmer Paixão IC
Future Virol; 2023 Sep; 18(13):865-880. PubMed ID: 37974899
[TBL] [Abstract][Full Text] [Related]
27. Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under invitro conditions.
Hasan A; Devi Ms S; Sharma G; Narayanan V; Sathiyarajeswaran P; Vinayak S; Sunil S
J Ethnopharmacol; 2023 Feb; 302(Pt A):115762. PubMed ID: 36181982
[TBL] [Abstract][Full Text] [Related]
28. Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro.
von Rhein C; Weidner T; Henß L; Martin J; Weber C; Sliva K; Schnierle BS
Antiviral Res; 2016 Jan; 125():51-7. PubMed ID: 26611396
[TBL] [Abstract][Full Text] [Related]
29. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
[TBL] [Abstract][Full Text] [Related]
30. The chikungunya virus E1 glycoprotein fusion loop and hinge alter glycoprotein dynamics leading to cell and host specific changes in infectivity.
Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
bioRxiv; 2023 Nov; ():. PubMed ID: 37961096
[TBL] [Abstract][Full Text] [Related]
31. Memantine hydrochloride: a drug to be repurposed against Chikungunya virus?
Pereira AKDS; Santos IA; da Silva WW; Nogueira FAR; Bergamini FRG; Jardim ACG; Corbi PP
Pharmacol Rep; 2021 Jun; 73(3):954-961. PubMed ID: 33523405
[TBL] [Abstract][Full Text] [Related]
32. A Chikungunya Virus
Bartholomeeusen K; Utt A; Coppens S; Rausalu K; Vereecken K; Ariën KK; Merits A
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695432
[TBL] [Abstract][Full Text] [Related]
33.
Chaudhary M; Sehgal D
J Biomol Struct Dyn; 2022; 40(22):11560-11570. PubMed ID: 34355667
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of silymarin against chikungunya virus.
Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
[TBL] [Abstract][Full Text] [Related]
35. An E3 Ubiquitin Ligase Scaffolding Protein Is Proviral during Chikungunya Virus Infection in Aedes aegypti.
Dubey SK; Mehta D; Chaudhary S; Hasan A; Sunil S
Microbiol Spectr; 2022 Jun; 10(3):e0059522. PubMed ID: 35435754
[TBL] [Abstract][Full Text] [Related]
36. Mosquito saliva induced cutaneous events augment Chikungunya virus replication and disease progression.
Agarwal A; Joshi G; Nagar DP; Sharma AK; Sukumaran D; Pant SC; Parida MM; Dash PK
Infect Genet Evol; 2016 Jun; 40():126-135. PubMed ID: 26925703
[TBL] [Abstract][Full Text] [Related]
37. Antiviral activity of stearylamine against chikungunya virus.
Jeengar MK; Kurakula M; Patil P; More A; Sistla R; Parashar D
Chem Phys Lipids; 2021 Mar; 235():105049. PubMed ID: 33422549
[TBL] [Abstract][Full Text] [Related]
38. The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.
Matkovic R; Bernard E; Fontanel S; Eldin P; Chazal N; Hassan Hersi D; Merits A; Péloponèse JM; Briant L
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463980
[TBL] [Abstract][Full Text] [Related]
39. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
Weber C; Sliva K; von Rhein C; Kümmerer BM; Schnierle BS
Antiviral Res; 2015 Jan; 113():1-3. PubMed ID: 25446334
[TBL] [Abstract][Full Text] [Related]
40. Targeting Chikungunya Virus Entry: Alternatives for New Inhibitors in Drug Discovery.
Silva LR; Rodrigues ÉEDS; Taniele-Silva J; Anderson L; Araújo-Júnior JX; Bassi ÊJ; Silva-Júnior EFD
Curr Med Chem; 2022; 29(4):612-634. PubMed ID: 34165405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
